Aktis Oncology, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Aktis Oncology, Inc. (AKTS) is 701.09M

According to Aktis Oncology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 701.09M. This represents a change of -16.09% compared to the average of 835.53M of the last 4 quarters.

Aktis Oncology, Inc. (AKTS) Historical Enterprise Value (quarterly & annually)

How has AKTS Enterprise Value performed in the past?

The mean historical Enterprise Value of Aktis Oncology, Inc. over the last ten years is 831.27M. The current 701.09M Enterprise Value has changed -15.66% with respect to the historical average. Over the past ten years (40 quarters), AKTS's Enterprise Value was at its highest in in the June 2026 quarter at 1.71B. The Enterprise Value was at its lowest in in the September 2024 quarter at -212236000.00.

Aktis Oncology, Inc. (AKTS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aktis Oncology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aktis Oncology, Inc. (AKTS) Average Enterprise Value

How has AKTS Enterprise Value performed in the past?

The current Enterprise Value of Aktis Oncology, Inc. (AKTS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Aktis Oncology, Inc. (AKTS) Enterprise Value vs. Peers

How is AKTS’s Enterprise Value compared to its peers?

Aktis Oncology, Inc.’s Enterprise Value is greater than Bicycle Therapeutics plc (-203591299.00), greater than Akari Therapeutics, Plc (12.03M), less than Immunome, Inc. (2.07B), greater than MacroGenics, Inc. (74.50M), less than Immunocore Holdings plc (1.49B), greater than Aura Biosciences, Inc. (568.91M),

Build a custom stock screener for Aktis Oncology, Inc. (AKTS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aktis Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aktis Oncology, Inc. (AKTS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aktis Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.